Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Fentanyl in allen Darreichungsformen, ausgenommen Matrixpflaster und Tabletten (ATC-Code: N02AB03).

Conclusion of a non-exclusive rebate contract pursuant to § 130a, para 8 SGB V for medicines containing the active substance Fentanyl in all dosage forms, except for matrix patches and tablets (ATC code: N02AB03) within the period from 01.05.2026 to 30.04.2028 with the possibility of concluding the contract at any time during the contract period (open-house model).